Olema Pharmaceuticals Inc (OLMA)

Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	15.85%67.18	57.99	50.08	45.88	47.86
Research and Development	17.37%57.79	49.23	43.22	39.95	43.90
Operating Income/Loss	15.85%-67.18	-57.99	-50.08	-45.88	-47.86
Nonoperating Income/Loss	18.75%3.98	4.90	4.02	3.66	4.08
	19.05%-63.20	-53.09	-46.06	-42.22	-43.78
Attributable To Parent	19.05%-63.20	-53.09	-46.06	-42.22	-43.78
Basic Average Shares	1.61%104.45	102.80	-	85.73	85.50
Diluted Average Shares	1.61%104.45	102.80	-	85.73	85.50
Basic Earnings Per Share	17.31%-0.61	-0.52	-	-0.49	-0.51
Diluted Earnings Per Share	17.31%-0.61	-0.52	-	-0.49	-0.51